Annual Secretarial Compliance Report for the year ended on March 31, 2026
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Kidney and Superspeciality Limited, listed on BSE and NSE in December 2025, has submitted its first Annual Secretarial Compliance Report for FY 2025-26. The report reveals two compliance violations: (1) late submission of financial results for Q2 FY26 (quarter ended September 2025) by 5 months, resulting in a fine of Rs 2.90 lakh each from BSE and NSE; (2) failure to give prior intimation to stock exchanges about the board meeting to approve Q2 results, resulting in a fine of Rs 10,000 each from BSE and NSE. Both violations occurred as the company was transitioning to listed entity status post-IPO. The company has paid the fines and submitted the delayed financial results. All other compliance requirements including secretarial standards, insider trading norms, related party transactions, and document preservation were met.
Minor compliance concern for a newly listed company. The violations have been compounded and resolved. No material impact on operations expected, though investors should note this is a recently listed entity still adapting to listing obligations.